Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1993-10-29
1999-01-26
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
4241841, 4242771, 514 2, 530300, 530324, 530325, 530326, 530327, 530328, 530350, 530380, 530395, 530827, 530828, 530829, 530837, 530838, 930 10, A61K 3900, A61K 3804, A61K 3808, A61K 3810
Patent
active
058635408
ABSTRACT:
The present invention relates, in general, to a method of treating inflammation or inhibiting cancer cell metastasis. In particular, the present invention relates to a method of suppressing T cell activation, inhibiting CD44-mediated cell adhesion and CD44-monocyte IL1 release, treating inflammation, and transporting a drug to a site of inflammation.
REFERENCES:
patent: 5002873 (1991-03-01), St. John et al.
patent: 5108904 (1992-04-01), Landay
Avrameas, "Coupling of Enzymes to Proteins with Glutaraldehyde. Use of Conjugates for the Detection of Antigens and Antibodies", Immunochemistry 6:43-53 (1969).
Aruffo et al, "CD44 is the Principal Cell Surface Receptor for Hyaluronate", Cell 61:1303-1313 (1990).
Arch et al, "Participation in Normal Immune Responses of a Metastasis-Inducing Splice Variant of CD44", Science 257:682-685 (1992).
Kahn, "Adhesion Protein Studies Provide New Clue to Metastasis", Science 257:614 (1992).
Stamenkovic et al, "The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluraonate-bearing cells", EMBO Journal 10(2):343-348 (1991).
Dougherty et al, Moleculear Cloning of CD44R1 and CD44R2, Two Novel Isoforms of the Human CD44 Lymphocyte `Homing` Receptor Expressed by Hemopoietic Cells, Terry Fox Lab. 15:54 (1991).
Gunthert et al, "A New Variant of Glycoprotein CD44 Confers Metastatic Potential to Rat Carcinoma Cells", Cell. 65:13-24 (1991).
Sy et al, "Distinct Effects of Two CD44 Isoforms on Tumor Growth In Vivo", J. Exp. Med. 174:859-866 (1991).
Hofmann et al, CD44 Splice Variants Confer Metastatic Behavior in Rats: Homologous Sequences Are Expressed in Human Tumor Cell Lines, Cancer Research 51:5292-5297 (1991).
Jackson et al, "Multiple Variants of the Human Lymphocyte Homing Receptor CD44 Generated by Insertions at a Single Site in the Extracellular Domain", J. of Biological Chemistry 267(7):4732-4739 (1992).
Goldstein et al, "A Human Lymphocyte Homing Receptor, the Hermes Antigen, is Related to Cartilage Proteoglycan Core and Link Proteins", Cell. 56:1063-1072 (1989).
Haynes et al, "CD44-A molecule involved in leukocyte adherence and T-cell activation", Immunology Today 10(12):423-428 (1989).
Wolffe et al, "The cDNA Sequence of Mouse Pgp-1 and Homolgoy to Hyman CD44 Cell Surface Antigen and Proteoglycan Core/Link Proteins", J. of Biological Chemistry 265(1):341-347 (1990).
Haynes et al, "The Transmembrane Hyaluronate Receptor (CD44): Multiple Functions, Multiple Forms", Cancer Cells 3(9):347-350 (1991).
Ware et al, "Characterization of the Surface Topograph and Putative Tertiary Structure of the Human CD7 Molecule", J. of Immunology 143(11):3632-3640 (1969).
Haynes et al, "Measurement of an Adhesion Molecule as an Indicator of Inflammatory Disease Activity", Arthritis and Rheumatism 34(11):1434-1443 (1991).
Culty et al, "The Hyaluronate Receptor is a Member of the CD44 (H-CAM) Family of Cell Surface Glycoproteins", The Journal of Cell Biology 111(6/Pt.1):27655-2774 (1990).
Lesley et al, "CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells", Eur. J. Immunol. 11:2719-2723 (1992).
Lesley et al, Binding of Hyaluronic Acid to Lymphoid Cell Lines Is Inhibited by Monoclonal Antibodies against Pgp-1 (Experimental Cell Research 187:224-233 (1990).
Miyake et al, "Hyaluronate Can Function as a Cell Adhesion Molecule and CD44 Participates in Hyaluronate Recognition", J. Exp. Med. 172:69-75 (1990).
Lesley et al, "Requirement for Hyaluronic Acid Binding by CD44: A Role for the Cytoplasmic Domain and Activation by Antibody", J. Exp. Med. 175:257-266 (1992).
Peach et al, "Identification of Hyaluronic Acid Binding Sites in the Extracellular Domain of CD44", The Journal of Cell Biology 122(1):257-264 (1993).
Goetinck et al, "The Tandemly Repeated Sequences of Cartilage Link Protein Contain the Sites for Interaction with Hyaluronic Acid", The Journal of Cell Biology 105:2403-2408 (1987).
He et al, "Molecular Isoforms of Murine CD44 and Evidence That the Membrane Proximal Domain Is Not Critical for Hyaluronate Recognition", The Journal of Cell Biology 119(6):1711-1719 (1992).
Seiter et al, "Prevention of Tumor Metastasis Formation by Anti-Variant CD44", J. Exp. Med. 177:443-455 (1993).
Heider et al, "A Human Homologue of the Rat Metastasis-associated Variant of CD44 Is Expressed in Colorectal Carcinomas and Adenomatous Polyps", The Journal of Cell Biology 120(1):227-233 (1993).
Koopman et al, "Activated Human Lymphocytes and Agressive Non-Hodgkin's Lymphomas Express a Homologue of the Rat Metastasis-associated Variant of CD44", J. Exp. Med. 177:897-904 (1993).
Thomas et al, "CD44H Regulates Tumor Cell Migration on Hyaluronate-coated Substrate", The Journal of Cell Biology 118(4):971-977 (1992).
Turley et al, "Hyaluronan and a Cell-associated Hyaluronan Binding Protein Regulate the Locomotion of Ras-transformed Cells", The Journal of Cell Biology 112(5):1041-1047 (1991).
Kumar, V. et al. Proc. Natl. Acad. Sci USA 87:1337-1341, 1990.
Haynes, B.F. Springer Sum. Immunopatnol. 11:163-185, 1989.
Cohen, J. Science 262(5):841-843, Nov. 1993. Pgp-1 Antigens in Man Recognize the Hermes Class of Lymphocyte Homing Receptors", The Journal of Immunology 142(6):2046-2051 (1989).
Hale et al, "CD44 Antibody Against In(Lu)-Related p80, Lymphocyte-Homing Receptor Molecule Inhibits the Binding of Human Erythrocytes to T Cells", The Journal of Immunology 143(12):3944-3948 (1989).
Denning et al, "Antibodies Against the CD44 p80, Lymphocyte Homing Receptor Molecule Augument Human Peripheral Blood T Cell Activation", The Journal of Immunology 144(1):7-15 (1990).
Miyake et al, "Monoclonal Antibodies to Pgp-1/CD44 Block Lympho-Hemopoiesis in Long-Term Blone Marrow Cultures", 171:477-488 (1990).
Cohen, Jon, "Cancer Vaccines Get a Shot in the Arm", Science 262:841-843 (1993).
Haynes et al, "Differentiation of Human T Lymphocytes: 1. Acquisition of a Novel Human Cell Surface Protein (p80) During Normal Intrathymic T Cell Maturation", The Journal of Immunolgy 131(3):1195-1200 (1983).
Telen al, "Human Erythrocyte Antigens" Regulation of Expression of a Novel Erythrocyte Surface Antigen by the Inhibitor Lutheran In(Lu) Gene, J. Clin. Inves. 71:1878-1886 (1983).
"Biochemicals Organic Compounds for Research and Diagnostic Reagents" Sigma Catalog, pp. 1118-1119 (1992).
Fundamental Immunology, Third Edition, William E. Paul, M.D., Editor, Raven Press, New York, Ch. 8, p. 242.
Guo et al, "HIV-Induced Loss of CD44 Expression in Monocytic Cell Lines", The Journal of Immunology 151(4):2225-22236 (1993).
Rivadeneira et al, "Inhibition of HIV Type 1 Infection of Mononuclear Phagocytes by Anti-CD44 Antibodies", AIDS Research and Human Retroviruses 11(5):541-546 (1995).
Willerford et al, "Simian Immunodeficiency Virus is Restricted to a Subset of Blood CD4+ Lymphocytes that Includes Memory Cells", The Journal of Immunology 144(10):3779-3783 (1990).
Matsushita et al, "Selective Killing of HIV-Infected Cells by Anti-gp 120 Immunotoxins", AIDS Research and Human Retroviruses 6(2):193-203 (1990).
Nicholson et al, "In Vitro of Human Monocytes With Human T Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus (HTLV-III/LAV)", The Journal of Immunology 137(1):323-329 (1986).
Hirsch et al, "Therapy for Human Immunodeficiency Virus Infection", The New England Journal of Medicine 1686-1695 (1993).
Fahey et al, "Status of immune-based therapies in HIV infection and AIDS", Clin. exp. Immunol. 88:1-5 (1992).
Edgington, Stephen M., "How Sweet It Is: Selectin-Mediating Drugs", Bio/Technology 10:383-389 (1992).
Shaffer, Marjorie, "Drug giants, start-ups target adhesion molecules, key to inflammatory disease", Biotechnology Newswatch, p. 9, Oct. 4, 1993.
Harris et al, "Therapeutic antibodies--the coming of age", TIBTECH 11:42-44 (1993).
Haynes Barton F.
Liao Hua-Xin
Patton Karen L.
Caputa Anthony C.
Duke University
LandOfFree
Adhesion molecule does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adhesion molecule, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adhesion molecule will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1448144